Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stromal Cells for Children With Type 3 Osteogenesis Imperfecta
NCT05559801Phase 2Not yet recruiting
- Sponsor
- Emory University
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Modality
- Mesenchymal Stem Cells
01
Overview
A Phase 2 trial of Provacel in osteogenesis imperfecta (OI), sponsored by Emory University. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Provacel
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT05559801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05559801.